Calcium channel blockers: their pharmacologic and therapeutic role in hypertension

Area of Science:

• Cardiology
• Pharmacology

Background:

• Hypertension prevalence is rising in the US, disproportionately affecting African Americans.
• Many patients have inadequately controlled blood pressure (BP), often requiring multiple medications.
• Calcium channel blockers (CCBs) are a major class of antihypertensives, with dihydropyridine and nondihydropyridine subclasses.

Purpose of the Study:

• To examine the pharmacologic and clinical effects of CCBs in essential hypertension.
• To understand the role of CCBs in specific patient groups, including African Americans and those with renal disease.
• To elucidate the reasons behind the renewed popularity of CCBs in combination therapy.

Main Methods:

• Review of pharmacologic properties of CCBs.
• Analysis of clinical trial data on CCB efficacy and safety.
• Examination of CCB use in diverse patient populations.

Main Results:

• CCBs remain a cornerstone of hypertension management.
• Their efficacy in combination regimens is key to improved BP control.
• CCBs are effective in specific populations like African Americans and patients with renal disease.

Conclusions:

• CCBs are integral to modern hypertension treatment strategies.
• Fixed-dose combination regimens featuring CCBs offer improved BP control and cardiovascular risk reduction.
• Understanding CCB pharmacology and clinical application is vital for optimizing patient outcomes.